Phase 2 Bunionectomy HTX-011 Administration Study

NCT03718039 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Pain

Interventions

DRUG: HTX-011
DEVICE: Luer Lock applicator
DEVICE: Vial access device
DRUG: aprepitant

Sponsor

Heron Therapeutics